BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38099328)

  • 21. Role of medical treatment of endometriosis.
    Martone S; Troìa L; Marcolongo P; Luisi S
    Minerva Obstet Gynecol; 2021 Jun; 73(3):304-316. PubMed ID: 34008385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical treatment of endometriosis-related pain.
    Vercellini P; Buggio L; Frattaruolo MP; Borghi A; Dridi D; Somigliana E
    Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():68-91. PubMed ID: 29530425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometriosis: an overview of Cochrane Reviews.
    Brown J; Farquhar C
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD009590. PubMed ID: 24610050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal treatments for endometriosis: The endocrine background.
    Vannuccini S; Clemenza S; Rossi M; Petraglia F
    Rev Endocr Metab Disord; 2022 Jun; 23(3):333-355. PubMed ID: 34405378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacotherapy for pelvic endometriosis in women].
    Starczewski A; Brodowska A; Brodowski J
    Pol Merkur Lekarski; 2009 Mar; 26(153):231-3. PubMed ID: 19388539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of elagolix for the treatment of endometriosis.
    Melis GB; Neri M; Corda V; Malune ME; Piras B; Pirarba S; Guerriero S; Orrù M; D'Alterio MN; Angioni S; Paoletti AM
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):581-8. PubMed ID: 27021205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical Management of Endometriosis in Patients with Chronic Pelvic Pain.
    Bedaiwy MA; Allaire C; Yong P; Alfaraj S
    Semin Reprod Med; 2017 Jan; 35(1):38-53. PubMed ID: 28002850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis.
    Barra F; Scala C; Ferrero S
    Expert Opin Drug Metab Toxicol; 2018 Apr; 14(4):399-415. PubMed ID: 29617576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of early drug development for endometriosis.
    Leone Roberti Maggiore U; Ferrero S
    Expert Opin Investig Drugs; 2016; 25(2):227-47. PubMed ID: 26619754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal therapies for endometriosis: implications for bone metabolism.
    Dawood MY
    Acta Obstet Gynecol Scand Suppl; 1994; 159():22-34. PubMed ID: 8209669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the medical treatment of adolescent endometriosis.
    Yang L; Yu J; Zhang S; Zhang J
    Minerva Pediatr (Torino); 2023 Jun; 75(3):423-431. PubMed ID: 34309341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis-related pain.
    Ezzati M; Carr BR
    Womens Health (Lond); 2015 Jan; 11(1):19-28. PubMed ID: 25581052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
    Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
    Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone receptor ligands for the treatment of endometriosis.
    Clemenza S; Capezzuoli T; Eren E; Garcia Garcia JM; Vannuccini S; Petraglia F
    Minerva Obstet Gynecol; 2023 Jun; 75(3):288-297. PubMed ID: 36255163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the medical treatment of endometriosis.
    Minjarez DA; Schlaff WD
    Obstet Gynecol Clin North Am; 2000 Sep; 27(3):641-51. PubMed ID: 10958009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical Management of Endometriosis.
    Rafique S; Decherney AH
    Clin Obstet Gynecol; 2017 Sep; 60(3):485-496. PubMed ID: 28590310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical treatment of endometriosis.
    Garcia-Velasco JA; Quea G
    Minerva Ginecol; 2005 Jun; 57(3):249-55. PubMed ID: 16166934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing gonadotropin-releasing hormone agonist therapy in women with endometriosis.
    Olive DL
    Treat Endocrinol; 2004; 3(2):83-9. PubMed ID: 15743104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in targeting estrogen synthesis and receptors in patients with endometriosis.
    Clemenza S; Vannuccini S; Ruotolo A; Capezzuoli T; Petraglia F
    Expert Opin Investig Drugs; 2022 Nov; 31(11):1227-1238. PubMed ID: 36529967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of GnRH antagonists in the treatment of endometriosis.
    Küpker W; Felberbaum RE; Krapp M; Schill T; Malik E; Diedrich K
    Reprod Biomed Online; 2002; 5(1):12-6. PubMed ID: 12470539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.